Document is current
Any future updates will be listed below
-
Authors
Hummel, Julia http://orcid.org/0000-0002-9724-8365
Benkendorff, Charlotte http://orcid.org/0000-0001-8462-8492
Fritsche, Louise http://orcid.org/0000-0003-0644-6161
Prystupa, Katsiaryna http://orcid.org/0000-0003-3368-1028
Vosseler, Andreas http://orcid.org/0000-0002-6351-9673
Gancheva, Sofiya
Trenkamp, Sandra http://orcid.org/0000-0003-1419-7177
Birkenfeld, Andreas L. http://orcid.org/0000-0003-1407-9023
Preissl, Hubert http://orcid.org/0000-0002-8859-4661
Roden, Michael http://orcid.org/0000-0001-8200-6382
Häring, Hans-Ulrich
Fritsche, Andreas
Peter, Andreas
Wagner, Robert http://orcid.org/0000-0002-6120-0191
Kullmann, Stephanie http://orcid.org/0000-0001-9951-923X
Heni, Martin http://orcid.org/0000-0002-8462-3832
-
Funding
Funding for this research was provided by:
German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research
- License Information
-
More Information
Article History
Received: 1 December 2022
Accepted: 19 July 2023
First Online: 21 September 2023
Competing interests
: M.R. served on scientific advisory boards of Bristol-Myers Squibb, Eli Lilly, Fishawack Group, Gilead Sciences, Novo Nordisk and Target RWE and received investigator-initiated support from Boehringer Ingelheim, Nutricia/Danone and Sanofi-Aventis. A.F. reports lecture fees from Sanofi, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, AstraZeneca and Synlab and serves as a consultant for Novo Nordisk and Sanofi. R.W. reports lecture fees from Novo Nordisk and Sanofi. R.W. served on an advisory board for Akcea Therapeutics, Daiichi Sankyo, Sanofi and Novo Nordisk. S.K. reports lecture fees from Novo Nordisk and serves as a consultant for Boehringer Ingelheim. Outside of the current work, M.H. reports research grants from Boehringer Ingelheim and Sanofi to the University Hospital of Tübingen, participation on an advisory board for Boehringer Ingelheim, Sanofi and Amryt and lecture fees from Amryt, Sanofi, Eli Lilly, Novo Nordisk and Boehringer Ingelheim. All other authors have no competing interests.
